{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T15:45:30Z","timestamp":1758123930620},"reference-count":111,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,7,1]]},"DOI":"10.1093\/jac\/dki168","type":"journal-article","created":{"date-parts":[[2005,5,27]],"date-time":"2005-05-27T00:25:36Z","timestamp":1117153536000},"page":"10-19","source":"Crossref","is-referenced-by-count":11,"title":["Stampidine: a selective oculo-genital microbicide"],"prefix":"10.1093","volume":"56","author":[{"given":"Osmond J.","family":"D'Cruz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatih M.","family":"Uckun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,5,26]]},"reference":[{"key":"key\n\t\t\t\t20171012190543_B1","doi-asserted-by":"crossref","unstructured":"Ford E, Nelson KE, Warren D. Epidemiology of epidemic keratoconjunctivitis. Epidemiol Rev1987; 9: 244\u201361.","DOI":"10.1093\/oxfordjournals.epirev.a036304"},{"key":"key\n\t\t\t\t20171012190543_B2","doi-asserted-by":"crossref","unstructured":"Warren D, Nelson KE, Farrar JA et al. A large outbreak of epidemic keratoconjunctivitis: problems in controlling nosocomial spread. J Infect Dis1989; 160: 938\u201343.","DOI":"10.1093\/infdis\/160.6.938"},{"key":"key\n\t\t\t\t20171012190543_B3","doi-asserted-by":"crossref","unstructured":"McMinn PC, Stewart J, Burrell CJ. A community outbreak of epidemic keratoconjunctivitis in central Australia due to adenovirus type 8. J Infect Dis1991; 164: 1113\u20138.","DOI":"10.1093\/infdis\/164.6.1113"},{"key":"key\n\t\t\t\t20171012190543_B4","doi-asserted-by":"crossref","unstructured":"Takeuchi S, Itoh N, Uchio E et al. Adenovirus strains of subgenus D associated with nosocomial infection as new etiological agents of epidemic keratoconjunctivitis in Japan. J Clin Microbiol1999; 37: 3392\u20134.","DOI":"10.1128\/JCM.37.10.3392-3394.1999"},{"key":"key\n\t\t\t\t20171012190543_B5","doi-asserted-by":"crossref","unstructured":"Chang CH, Lin KH, Sheu MM et al. The change of etiological agents and clinical signs of epidemic viral conjunctivitis over an 18-year period in southern Taiwan. Graefes Arch Clin Exp Ophthalmol2003; 241: 554\u201360.","DOI":"10.1007\/s00417-003-0680-2"},{"key":"key\n\t\t\t\t20171012190543_B6","doi-asserted-by":"crossref","unstructured":"D'Angelo LJ, Hierholzer JC, Keenlyside RA et al. Pharyngoconjunctival fever caused by adenovirus type 4: report of a swimming pool-related outbreak with recovery of virus from pool water. J Infect Dis1979; 140: 42\u20137.","DOI":"10.1093\/infdis\/140.1.42"},{"key":"key\n\t\t\t\t20171012190543_B7","doi-asserted-by":"crossref","unstructured":"Uchio E, Matsuura N, Takeuchi S et al. Acute follicular conjunctivitis caused by adenovirus type 34. Am J Ophthalmol1999; 128: 680\u20136.","DOI":"10.1016\/S0002-9394(99)00238-X"},{"key":"key\n\t\t\t\t20171012190543_B8","doi-asserted-by":"crossref","unstructured":"Darougar S, Quinlan MP, Gibson JA et al. Epidemic keratoconjunctivitis and chronic papillary conjunctivitis in London due to adenovirus type 19. Br J Ophthalmol1977; 61: 76\u201385.","DOI":"10.1136\/bjo.61.2.76"},{"key":"key\n\t\t\t\t20171012190543_B9","doi-asserted-by":"crossref","unstructured":"Martone WJ, Hierholzer JC, Keenlyside RA et al. An outbreak of adenovirus type 3 disease at a private recreation center swimming pool. Am J Epidemiol1980; 111: 229\u201337.","DOI":"10.1093\/oxfordjournals.aje.a112890"},{"key":"key\n\t\t\t\t20171012190543_B10","unstructured":"Mueller AJ, Klauss V. Main sources of infection in 145 cases of epidemic keratoconjunctivitis. Ger J Ophthalmol1993; 2: 224\u20137."},{"key":"key\n\t\t\t\t20171012190543_B11","doi-asserted-by":"crossref","unstructured":"Jernigan JA, Lowry BS, Hayden FG et al. Adenovirus type 8 epidemic keratoconjunctivitis in an eye clinic: risk factors and control. J Infect Dis1993; 167: 1307\u201313.","DOI":"10.1093\/infdis\/167.6.1307"},{"key":"key\n\t\t\t\t20171012190543_B12","doi-asserted-by":"crossref","unstructured":"Chhabra BK. Nosocomial transmission of epidemic keratoconjunctivitis to food handlers in a nursing home. J Am Geriatr Soc1995; 43: 1392\u20133.","DOI":"10.1111\/j.1532-5415.1995.tb06619.x"},{"key":"key\n\t\t\t\t20171012190543_B13","doi-asserted-by":"crossref","unstructured":"Koo D, Bouvier B, Wesley M et al. Epidemic keratoconjunctivitis in a university medical center ophthalmology clinic; need for re-evaluation of the design and disinfection of instruments. Infect Control Hosp Epidemiol1989; 10: 547\u201352.","DOI":"10.2307\/30144235"},{"key":"key\n\t\t\t\t20171012190543_B14","doi-asserted-by":"crossref","unstructured":"Azar MJ, Dhaliwal DK, Bower KS et al. Possible consequences of shaking hands with your patients with epidemic keratoconjunctivitis. Am J Ophthalmol1996; 121: 711\u20132.","DOI":"10.1016\/S0002-9394(14)70640-3"},{"key":"key\n\t\t\t\t20171012190543_B15","unstructured":"Harley D, Harrower B, Lyon M et al. A primary school outbreak of pharyngoconjunctival fever caused by adenovirus type 3. Commun Dis Intell2001; 25: 9\u201312."},{"key":"key\n\t\t\t\t20171012190543_B16","doi-asserted-by":"crossref","unstructured":"Chaberny IE, Schnitzler P, Geiss HK et al. An outbreak of epidemic keratoconjunctivitis in a pediatric unit due to adenovirus type 8. Infect Control Hosp Epidemiol2003; 24: 514\u20139.","DOI":"10.1086\/502247"},{"key":"key\n\t\t\t\t20171012190543_B17","doi-asserted-by":"crossref","unstructured":"Nauheim RC, Romanowski EG, Araullo-Cruz T et al. Prolonged recoverability of desiccated adenovirus type 19 from various surfaces. Ophthalmology1990; 97: 1450\u20133.","DOI":"10.1016\/S0161-6420(90)32389-8"},{"key":"key\n\t\t\t\t20171012190543_B18","doi-asserted-by":"crossref","unstructured":"Kowalski RP, Romanowski EG, Waikhom B et al. The survival of adenovirus in multidose bottles of topical fluorescein. Am J Ophthalmol1998; 126: 835\u20136.","DOI":"10.1016\/S0002-9394(98)00252-9"},{"key":"key\n\t\t\t\t20171012190543_B19","doi-asserted-by":"crossref","unstructured":"Gordon YJ, Gordon RY, Romanowski E et al. Prolonged recovery of desiccated adenoviral serotypes 5, 8, and 19 from plastic and metal surfaces in vitro. Ophthalmology1993; 100: 1835\u20139.","DOI":"10.1016\/S0161-6420(93)31389-8"},{"key":"key\n\t\t\t\t20171012190543_B20","unstructured":"Croes K. Contact lens market: higher-value products, favorable demographics and international expansion create an accelerating growth industry. OptiStock Optical Sector Report October 2003. http:\/\/www.optistock.com\/mw\/2003_10all.htm (15 April 2005, date last accessed)."},{"key":"key\n\t\t\t\t20171012190543_B21","doi-asserted-by":"crossref","unstructured":"Mah-Sadorra JH, Yavuz SG, Najjar DM et al. Trends in contact lens-related corneal ulcers. Cornea2005; 24: 51\u20138.","DOI":"10.1097\/01.ico.0000138839.29823.57"},{"key":"key\n\t\t\t\t20171012190543_B22","unstructured":"Pepose JS. Contact lens disinfection to prevent transmission of viral disease. CLAO J1988; 14: 165\u20138."},{"key":"key\n\t\t\t\t20171012190543_B23","unstructured":"Gordon JS, Aoki K, Kinchington PR. Adenovirus keratoconjunctivitis. In: Pepose JS, Holland GN, Wilhelmus KR, eds. Ocular Infection & Immunity. St Louis, MO, USA: Mosby, 1996; 877\u201394."},{"key":"key\n\t\t\t\t20171012190543_B24","doi-asserted-by":"crossref","unstructured":"Wadell G. Molecular epidemiology of human adenoviruses. Curr Top Microbiol Immunol1984; 110: 191\u2013220.","DOI":"10.1007\/978-3-642-46494-2_7"},{"key":"key\n\t\t\t\t20171012190543_B25","unstructured":"Horwitz MS. Adenoviruses. In: Fields BN, Knipe DM, eds. Virology 2nd edn. New York, NY, USA: Raven Press, 1990; 1723\u201340."},{"key":"key\n\t\t\t\t20171012190543_B26","unstructured":"Shenk T. Adenoviridae: the viruses and their replication. In: Fields BN, Knipe DM, Howley PM, eds. Fields Virology 3rd edn. Philadelphia, PA, USA: Lippincott-Raven Publishers, 1996; 2111\u201348."},{"key":"key\n\t\t\t\t20171012190543_B27","doi-asserted-by":"crossref","unstructured":"Jawetz EA, Kimura A, Nicholas N et al. New type of APC virus from keratoconjunctivitis. Science1955; 122: 1190\u20132.","DOI":"10.1126\/science.122.3181.1190-a"},{"key":"key\n\t\t\t\t20171012190543_B28","doi-asserted-by":"crossref","unstructured":"Aoki K, Tagawa Y. A twenty-one year surveillance of adenoviral conjunctivitis in Sapporo, Japan. Int Ophthalmol Clin2002; 42: 49\u201354.","DOI":"10.1097\/00004397-200201000-00008"},{"key":"key\n\t\t\t\t20171012190543_B29","unstructured":"Gordon JS. Adenovirus and other non-herpetic viral diseases. In: Smolin G, Thoft RA, eds. The Cornea 3rd edn. New York, NY, USA: Little, Brown and Company, 1994; 215\u201322."},{"key":"key\n\t\t\t\t20171012190543_B30","doi-asserted-by":"crossref","unstructured":"Darourgor S, Walpita P, Thaker U et al. Adenovirus serotypes isolated from ocular infections in London. Br J Ophthalmol1983; 67: 111\u20134.","DOI":"10.1136\/bjo.67.2.111"},{"key":"key\n\t\t\t\t20171012190543_B31","unstructured":"Kinchington PR, Turse SE, Kowalski RP et al. Use of polymerase chain amplification reaction for the detection of adenoviruses in ocular swab specimens. Invest Ophthalmol Vis Sci1994; 35: 4126\u201334."},{"key":"key\n\t\t\t\t20171012190543_B32","doi-asserted-by":"crossref","unstructured":"Corsaro D, Gut JP, Venard V et al. Molecular epidemiology of ocular isolates of adenovirus 8 obtained over nine years. J Clin Pathol1999; 52: 860\u20131.","DOI":"10.1136\/jcp.52.11.860"},{"key":"key\n\t\t\t\t20171012190543_B33","doi-asserted-by":"crossref","unstructured":"Chang CH, Sheu MM, Lin KH et al. Hemorrhagic viral keratoconjunctivitis in Taiwan caused by adenovirus types 19 and 37: applicability of polymerase chain reaction-restriction fragment length polymorphism in detecting adenovirus genotypes. Cornea2001; 20: 295\u2013300.","DOI":"10.1097\/00003226-200104000-00011"},{"key":"key\n\t\t\t\t20171012190543_B34","doi-asserted-by":"crossref","unstructured":"Pring-Akerblom P, Adrian T. Characterization of adenovirus subgenus D fiber genes. Virology1995; 206: 564\u201371.","DOI":"10.1016\/S0042-6822(95)80073-5"},{"key":"key\n\t\t\t\t20171012190543_B35","unstructured":"O'Donnell B, McCruden EA, Desselberger U. Molecular epidemiology of adenovirus conjunctivitis in Glasgow 1981\u20131991. Eye1993; 7: 8\u201314."},{"key":"key\n\t\t\t\t20171012190543_B36","unstructured":"Harley D, Harrower B, Lyon M et al. A primary school outbreak of pharyngoconjunctival fever caused by adenovirus type 3. Commun Dis Intell2001; 25: 9\u201312."},{"key":"key\n\t\t\t\t20171012190543_B37","doi-asserted-by":"crossref","unstructured":"Harnett GB, Newnham WA. Isolation of adenovirus type 19 from the male and female genital tracts. Br J Vener Dis1981; 57: 55\u20137.","DOI":"10.1136\/sti.57.1.55"},{"key":"key\n\t\t\t\t20171012190543_B38","doi-asserted-by":"crossref","unstructured":"Swenson PD, Lowens MS, Celum CL et al. Adenovirus types 2, 8, and 37 associated with genital infections in patients attending a sexually transmitted disease clinic. J Clin Microbiol1995; 33: 2728\u201331.","DOI":"10.1128\/JCM.33.10.2728-2731.1995"},{"key":"key\n\t\t\t\t20171012190543_B39","unstructured":"Cevenini R, Donati M, Landini MP et al. Adenoviruses associated with an oculo-genital infection. Microbiologica1979; 2: 425\u20137."},{"key":"key\n\t\t\t\t20171012190543_B40","doi-asserted-by":"crossref","unstructured":"Harnett GB, Phillips PA, Gollow MM. Association of genital adenovirus infection with urethritis in men. Med J Aust1984; 141: 337\u20138.","DOI":"10.5694\/j.1326-5377.1984.tb132799.x"},{"key":"key\n\t\t\t\t20171012190543_B41","unstructured":"Laverty CR, Russell P, Black J et al. Adenovirus infection of the cervix. Acta Cytol1977; 21: 114\u20137."},{"key":"key\n\t\t\t\t20171012190543_B42","doi-asserted-by":"crossref","unstructured":"Phillips PA, Harnett GB, Gollow MM. Adenovirus type 19 and a closely related new serotype in genital infection. Br J Vener Dis1982; 58: 131\u20132.","DOI":"10.1136\/sti.58.2.131"},{"key":"key\n\t\t\t\t20171012190543_B43","doi-asserted-by":"crossref","unstructured":"Arnberg N, Pring-Akerblom P, Wadell G. Adenovirus type 37 uses sialic acid as a cellular receptor on Chang C cells. J Virol2002; 76: 8834\u201341.","DOI":"10.1128\/JVI.76.17.8834-8841.2002"},{"key":"key\n\t\t\t\t20171012190543_B44","doi-asserted-by":"crossref","unstructured":"Arnberg N, Mei Y, Wadell G. Fiber genes of adenoviruses with tropism for the eye and the genital tract. Virology1997; 227: 239\u201344.","DOI":"10.1006\/viro.1996.8269"},{"key":"key\n\t\t\t\t20171012190543_B45","doi-asserted-by":"crossref","unstructured":"Hierholzer JC, Wigand R, Anderson LJ et al. Adenoviruses from patients with AIDS: a plethora of serotypes and a description of five new serotypes of subgenus D (types 43\u201347). J Infect Dis1988; 158: 804\u201313.","DOI":"10.1093\/infdis\/158.4.804"},{"key":"key\n\t\t\t\t20171012190543_B46","doi-asserted-by":"crossref","unstructured":"Green WR, Greaves WL, Frederick WR et al. Renal infection due to adenovirus in a patient with human immunodeficiency virus infection. Clin Infect Dis1994; 18: 989\u201391.","DOI":"10.1093\/clinids\/18.6.989"},{"key":"key\n\t\t\t\t20171012190543_B47","doi-asserted-by":"crossref","unstructured":"Khoo SH, Bailey AS, de Jong JC et al. Adenovirus infections in human immunodeficiency virus-positive patients: clinical features and molecular epidemiology. J Infect Dis1995; 172: 629\u201337.","DOI":"10.1093\/infdis\/172.3.629"},{"key":"key\n\t\t\t\t20171012190543_B48","doi-asserted-by":"crossref","unstructured":"Carrigan DR. Adenovirus infections in immunocompromised patients. Am J Med1997; 102: 71\u20134.","DOI":"10.1016\/S0002-9343(97)00015-6"},{"key":"key\n\t\t\t\t20171012190543_B49","doi-asserted-by":"crossref","unstructured":"De Jong JC, Wermenbol AG, Verweij-Uijterwaal MW et al. Adenoviruses from human immunodeficiency virus-infected individuals, including two strains that represent new candidate serotypes Ad50 and Ad51 of species B1 and D, respectively. J Clin Microbiol1999; 37: 3940\u20135.","DOI":"10.1128\/JCM.37.12.3940-3945.1999"},{"key":"key\n\t\t\t\t20171012190543_B50","doi-asserted-by":"crossref","unstructured":"Sabin CA, Clewley GS, Deayton JR et al. Shorter survival in HIV-positive patients with diarrhoea who excrete adenovirus from the GI tract. J Med Virol1999; 58, 280\u20135.","DOI":"10.1002\/(SICI)1096-9071(199907)58:3<280::AID-JMV14>3.0.CO;2-N"},{"key":"key\n\t\t\t\t20171012190543_B51","doi-asserted-by":"crossref","unstructured":"Koopmann J, Dombrowski F, Rockstroh JK et al. Fatal pneumonia in an AIDS patient coinfected with adenovirus and Pneumocystis carinii. Infection2000; 28: 323\u20135.","DOI":"10.1007\/s150100070028"},{"key":"key\n\t\t\t\t20171012190543_B52","doi-asserted-by":"crossref","unstructured":"Kojaoghlanian T, Flomenberg P, Horwitz MS. The impact of adenovirus infection on the immunocompromised host. Rev Med Virol2003; 13: 155\u201371.","DOI":"10.1002\/rmv.386"},{"key":"key\n\t\t\t\t20171012190543_B53","doi-asserted-by":"crossref","unstructured":"Perricone MA, Morris JE, Pavelka K et al. Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. II. Transfection efficiency in airway epithelium. Hum Gene Ther2001; 12: 1383\u201394.","DOI":"10.1089\/104303401750298544"},{"key":"key\n\t\t\t\t20171012190543_B54","doi-asserted-by":"crossref","unstructured":"Urabe M, Ding C, Kotin RM. Insect cells as a factory to produce adeno-associated virus type 2 vectors. Hum Gene Ther2002; 13: 1935\u201343.","DOI":"10.1089\/10430340260355347"},{"key":"key\n\t\t\t\t20171012190543_B55","doi-asserted-by":"crossref","unstructured":"Galanis E, Okuno SH, Nascimento AG et al. Phase I-II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas. Gene Ther2005; 12: 437\u201345.","DOI":"10.1038\/sj.gt.3302436"},{"key":"key\n\t\t\t\t20171012190543_B56","doi-asserted-by":"crossref","unstructured":"Sangro B, Mazzolini G, Ruiz J et al. Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors. J Clin Oncol2004; 22: 1389\u201397.","DOI":"10.1200\/JCO.2004.04.059"},{"key":"key\n\t\t\t\t20171012190543_B57","doi-asserted-by":"crossref","unstructured":"Tsubota K, Inoue H, Ando K et al. Adenovirus-mediated gene transfer to the ocular surface epithelium. Exp Eye Res1998; 67: 531\u20138.","DOI":"10.1006\/exer.1998.0557"},{"key":"key\n\t\t\t\t20171012190543_B58","doi-asserted-by":"crossref","unstructured":"Wu E, Fernandez J, Fleck SK et al. A 50-kDa membrane protein mediates sialic acid-independent binding and infection of conjunctival cells by adenovirus type 37. Virology2001; 279: 78\u201389.","DOI":"10.1006\/viro.2000.0703"},{"key":"key\n\t\t\t\t20171012190543_B59","doi-asserted-by":"crossref","unstructured":"Gaggar A, Shayakhmetov DM, Lieber A. CD46 is a cellular receptor for group B adenoviruses. Nature Med2003; 9: 1408\u201312.","DOI":"10.1038\/nm952"},{"key":"key\n\t\t\t\t20171012190543_B60","doi-asserted-by":"crossref","unstructured":"Wu E, Trauger SA, Pache L et al. Membrane cofactor protein is a receptor for adenoviruses associated with epidemic keratoconjunctivitis. J Virol2004; 78: 3897\u2013905.","DOI":"10.1128\/JVI.78.8.3897-3905.2004"},{"key":"key\n\t\t\t\t20171012190543_B61","doi-asserted-by":"crossref","unstructured":"Gipson IK, Argueso P. Role of mucins in the function of the corneal and conjunctival epithelia. Int Rev Cytol2003; 231: 1\u201349.","DOI":"10.1016\/S0074-7696(03)31001-0"},{"key":"key\n\t\t\t\t20171012190543_B62","doi-asserted-by":"crossref","unstructured":"D'Cruz OJ, Wild RA, Medders DE et al. Antigenic similarities between respiratory and reproductive tract mucins: heterogeneity of mucin expression by human endocervix and endometrium. Fertil Steril1993; 60: 1011\u20139.","DOI":"10.1016\/S0015-0282(16)56402-4"},{"key":"key\n\t\t\t\t20171012190543_B63","doi-asserted-by":"crossref","unstructured":"D'Cruz OJ, Dunn TS, Pichan P et al. Antigenic cross-reactivity of human tracheal mucin with human sperm and trophoblasts correlates with the expression of mucin 8 gene messenger ribonucleic acid in reproductive tract tissues. Fertil Steril1996; 66: 316\u201326.","DOI":"10.1016\/S0015-0282(16)58460-X"},{"key":"key\n\t\t\t\t20171012190543_B64","doi-asserted-by":"crossref","unstructured":"D'Cruz OJ, Wild RA. Evaluation of endometrial tissue specific complement activation in women with endometriosis. Fertil Steril1992; 57: 787\u201395.","DOI":"10.1016\/S0015-0282(16)54960-7"},{"key":"key\n\t\t\t\t20171012190543_B65","unstructured":"Bora NS, Gobleman CL, Atkinson JP et al. Differential expression of the complement regulatory proteins in the human eye. Invest Ophthalmol Vis Sci1993; 34: 3579\u201384."},{"key":"key\n\t\t\t\t20171012190543_B66","doi-asserted-by":"crossref","unstructured":"D'Cruz OJ, Haas GG Jr. The expression of the complement regulators CD46, CD55, and CD59 by human sperm does not protect them from antisperm antibody- and complement-mediated immune injury. Fertil Steril1993; 59; 876\u201384.","DOI":"10.1016\/S0015-0282(16)55875-0"},{"key":"key\n\t\t\t\t20171012190543_B67","doi-asserted-by":"crossref","unstructured":"Cocuzzi E, Szczotka LB, Brodbeck WG et al. Tears contain the complement regulator CD59 as well as decay-accelerating factor (DAF). Clin Exp Immunol2001; 123: 188\u201395.","DOI":"10.1046\/j.1365-2249.2001.01408.x"},{"key":"key\n\t\t\t\t20171012190543_B68","unstructured":"Duke-Elder S. System of Ophthalmology, Vol. VIII, Diseases of the Outer Eye, Part 1. St Louis, MO, USA: CV Mosby, 1965; 337\u201348."},{"key":"key\n\t\t\t\t20171012190543_B69","unstructured":"Gottsch JD. Surveillance and control of epidemic keratoconjunctivitis. Trans Am Ophthalmol Soc1996; 94: 539\u201387."},{"key":"key\n\t\t\t\t20171012190543_B70","unstructured":"Chodosh J, Astley RA, Butler MG et al. Adenovirus keratitis: a role for Interleukin 8. Invest Ophthalmol Vis Sci2000; 41: 783\u20139."},{"key":"key\n\t\t\t\t20171012190543_B71","doi-asserted-by":"crossref","unstructured":"Trousdale MD, Nobrega R, Wood RL et al. Role of adenovirus type 5 early region in the pathogenesis of ocular disease and cell culture infection. Cornea1995; 14: 280\u20139.","DOI":"10.1097\/00003226-199505000-00009"},{"key":"key\n\t\t\t\t20171012190543_B72","doi-asserted-by":"crossref","unstructured":"Jones BR. The clinical features of viral keratitis and a concept of their pathogenesis. Proc R Soc Med1958; 51: 13\u201320.","DOI":"10.1177\/003591575805101105"},{"key":"key\n\t\t\t\t20171012190543_B73","doi-asserted-by":"crossref","unstructured":"Reefschlager J, Brwolff D, Barwolff D et al. Efficiency and selectivity of (E)-5-(2-bromovinyl)-2\u2032-deoxyuridine and some other 5-substituted 2\u2032-deoxypyrimidine nucleosides as anti-herpes agents. Antiviral Res1982; 2: 41\u201352.","DOI":"10.1016\/0166-3542(82)90025-0"},{"key":"key\n\t\t\t\t20171012190543_B74","doi-asserted-by":"crossref","unstructured":"van der Vliet PC, Kwant MM. Role of DNA polymerase gamma in adenovirus DNA replication. Mechanism of inhibition by 2\u2032,3\u2032-dideoxynucleoside 5\u2032-triphosphates. Biochemistry1981; 20: 2628\u201332.","DOI":"10.1021\/bi00512a041"},{"key":"key\n\t\t\t\t20171012190543_B75","doi-asserted-by":"crossref","unstructured":"Mentel R, Kinder M, Wegner U et al. Inhibitory activity of 3\u2032-fluoro-2\u2032 deoxythymidine and related nucleoside analogues against adenoviruses in vitro. Antiviral Res1997; 34: 113\u20139.","DOI":"10.1016\/S0166-3542(97)01029-2"},{"key":"key\n\t\t\t\t20171012190543_B76","doi-asserted-by":"crossref","unstructured":"Mentel R, Kurek S, Wegner U et al. Inhibition of adenovirus DNA polymerase by modified nucleoside triphosphate analogs correlate with their antiviral effects on cellular level. Med Microbiol Immunol2000; 189; 91\u20135.","DOI":"10.1007\/s004300000046"},{"key":"key\n\t\t\t\t20171012190543_B77","doi-asserted-by":"crossref","unstructured":"Allen LB, Boswell KH, Khwaja TA et al. Synthesis and antiviral activity of some phosphates of the broad-spectrum antiviral nucleoside, 1-\u03b2-d-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin). J Med Chem1978; 21: 742\u20136.","DOI":"10.1021\/jm00206a005"},{"key":"key\n\t\t\t\t20171012190543_B78","doi-asserted-by":"crossref","unstructured":"Naesens L, Lenaerts L, Andrei G et al. Antiadenovirus activities of several classes of nucleoside and nucleotide analogues. Antimicrob Agents Chemother2005; 49: 1010\u20136.","DOI":"10.1128\/AAC.49.3.1010-1016.2005"},{"key":"key\n\t\t\t\t20171012190543_B79","doi-asserted-by":"crossref","unstructured":"Mul YM, van Miltenburg RT, De Clercq E et al. Mechanism of inhibition of adenovirus DNA replication by the acyclic nucleoside triphosphate analogue (S)-HPMPApp: influence of the adenovirus DNA binding protein. Nucleic Acids Res1989; 17: 8917\u201329.","DOI":"10.1093\/nar\/17.22.8917"},{"key":"key\n\t\t\t\t20171012190543_B80","doi-asserted-by":"crossref","unstructured":"De Clercq E. Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections. Clin Microbiol Rev2003; 16: 569\u201396.","DOI":"10.1128\/CMR.16.4.569-596.2003"},{"key":"key\n\t\t\t\t20171012190543_B81","doi-asserted-by":"crossref","unstructured":"Fanourgiakis P, Georgala A, Vekemans M et al. Intravesical instillation of cidofovir in the treatment of hemorrhagic cystitis caused by adenovirus type 11 in a bone marrow transplant recipient. Clin Infect Dis2005; 40: 199\u2013201.","DOI":"10.1086\/426594"},{"key":"key\n\t\t\t\t20171012190543_B82","doi-asserted-by":"crossref","unstructured":"Ljungman P. Treatment of adenovirus infections in the immunocompromised host. Eur J Clin Microbiol Infect Dis2004; 23: 583\u20138.","DOI":"10.1007\/s10096-004-1165-x"},{"key":"key\n\t\t\t\t20171012190543_B83","doi-asserted-by":"crossref","unstructured":"Maslo C, Girard PM, Urban T et al. Ribavirin therapy for adenovirus pneumonia in an AIDS patient. Am J Respir Crit Care Med1997; 156; 1263\u20134.","DOI":"10.1164\/ajrccm.156.4.97-02028"},{"key":"key\n\t\t\t\t20171012190543_B84","doi-asserted-by":"crossref","unstructured":"De Clercq E. Antiviral drugs in current clinical use. J Clin Virol2004; 30: 115\u201333.","DOI":"10.1016\/j.jcv.2004.02.009"},{"key":"key\n\t\t\t\t20171012190543_B85","unstructured":"Anekthananon T, Ratanasuwan W, Techasathit W et al. Safety and efficacy of a simplified fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) for the treatment of advanced HIV-infected patients: a 24-week study. J Med Assoc Thailand2004; 87: 760\u20137."},{"key":"key\n\t\t\t\t20171012190543_B86","doi-asserted-by":"crossref","unstructured":"Laurent C, Kouanfack C, Koulla-Shiro S et al. Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial. Lancet2004; 364: 29\u201334.","DOI":"10.1016\/S0140-6736(04)16586-0"},{"key":"key\n\t\t\t\t20171012190543_B87","doi-asserted-by":"crossref","unstructured":"Balzarini J, Herdewijn P, De Clercq E. Differential patterns of intracellular metabolism of 2\u2032,3\u2032-didehydro-2\u2032,3\u2032-dideoxythymidine and 3\u2032-azido-2\u2032,3\u2032-dideoxythymidine, two potent anti-human immunodeficiency virus compounds. J Biol Chem1989; 264; 6127\u201333.","DOI":"10.1016\/S0021-9258(18)83322-1"},{"key":"key\n\t\t\t\t20171012190543_B88","doi-asserted-by":"crossref","unstructured":"McIntee EJ, Remmel RP, Schinazi RF et al. Probing the mechanism of action and decomposition of amino acid phosphomonoester amidates of antiviral nucleoside prodrugs. J Med Chem1997; 40: 3323\u201331.","DOI":"10.1021\/jm960694f"},{"key":"key\n\t\t\t\t20171012190543_B89","doi-asserted-by":"crossref","unstructured":"McGuigan C, Cahard D, Sheeka M et al. Aryl phosphoramidate derivatives of d4T have improved anti-HIV efficacy in tissue culture and may act by the generation of a novel intracellular metabolite. J Med Chem1996; 39: 1748\u201353.","DOI":"10.1021\/jm950605j"},{"key":"key\n\t\t\t\t20171012190543_B90","doi-asserted-by":"crossref","unstructured":"D'Cruz OJ, Venkatachalam TK, Uckun FM. Thymidine kinase-independent intracellular delivery of bioactive nucleotides by aryl phosphate derivatives of bromo-methoxy zidovudine (compounds WHI-05 and WHI-07) in normal human female genital tract epithelial cells and sperm. Biol Reprod2001; 64: 51\u20139.","DOI":"10.1095\/biolreprod64.1.51"},{"key":"key\n\t\t\t\t20171012190543_B91","unstructured":"Vig R, Venkatachalam TK, Uckun FM. d4T-5\u2032-[p-bromophenyl methoxyalaninyl phosphate] as a potent and non-toxic anti-human immunodeficiency virus agent. Antivir Chem Chemother1998; 9: 445\u20138."},{"key":"key\n\t\t\t\t20171012190543_B92","doi-asserted-by":"crossref","unstructured":"Uckun FM, Pendergrass S, Qazi S et al. Phenyl phosphoramidate derivatives of stavudine as anti-HIV agents with potent and selective in-vitro antiviral activity against adenovirus. Eur J Med Chem2004; 39: 225\u201334.","DOI":"10.1016\/j.ejmech.2003.12.002"},{"key":"key\n\t\t\t\t20171012190543_B93","doi-asserted-by":"crossref","unstructured":"Uckun FM, Pendergrass S, Qazi S et al. In vitro activity of stampidine against primary clinical human immunodeficiency virus isolates. Arzneimittelforschung2004; 54: 69\u201377.","DOI":"10.1055\/s-0031-1296939"},{"key":"key\n\t\t\t\t20171012190543_B94","doi-asserted-by":"crossref","unstructured":"Uckun FM, Pendergrass S, Venkatachalam TK et al. Stampidine is a potent inhibitor of zidovudine and NRTI-resistant primary clinical HIV-1 isolates with thymidine analog mutations. Antimicrob Agents Chemother2002; 46, 3613\u20136.","DOI":"10.1128\/AAC.46.11.3613-3616.2002"},{"key":"key\n\t\t\t\t20171012190543_B95","doi-asserted-by":"crossref","unstructured":"Uckun FM, Samuel P, Qazi S et al. Effects of aryl substituents on the anti-HIV activity of the arylphosphoramidate derivatives of stavudine. Antivir Chem Chemother2002; 13: 197\u2013203.","DOI":"10.1177\/095632020201300306"},{"key":"key\n\t\t\t\t20171012190543_B96","doi-asserted-by":"crossref","unstructured":"Uckun FM, Qazi S, Pendergrass S et al. In vivo toxicity, pharmacokinetics, and anti-human immunodeficiency virus activity of stavudine-5\u2032-(p-bromophenyl methoxyalaninyl phosphate) (stampidine) in mice. Antimicrob Agents Chemother2002; 46: 3428\u201336.","DOI":"10.1128\/AAC.46.11.3428-3436.2002"},{"key":"key\n\t\t\t\t20171012190543_B97","doi-asserted-by":"crossref","unstructured":"Uckun FM, Chen CL, Samuel P et al. In vivo antiretroviral activity of stampidine in chronically feline immunodeficiency virus-infected cats. Antimicrob Agents Chemother2003; 47: 1233\u201340.","DOI":"10.1128\/AAC.47.4.1233-1240.2003"},{"key":"key\n\t\t\t\t20171012190543_B98","doi-asserted-by":"crossref","unstructured":"Chen CL, Yu G, Venkatachalam TK et al. Metabolism of stavudine-5\u2032-[p-bromophenyl methoxyalaninyl phosphate], stampidine, in mice, dogs, and cats. Drug Metab Dispos2002; 30: 1523\u201331.","DOI":"10.1124\/dmd.30.12.1523"},{"key":"key\n\t\t\t\t20171012190543_B99","doi-asserted-by":"crossref","unstructured":"Uckun FM, Chen CL, Lisowski E et al. Toxicity and pharmacokinetics of stampidine in mice and rats. Arzneimittelforschung2003; 53: 357\u201367.","DOI":"10.1055\/s-0031-1297120"},{"key":"key\n\t\t\t\t20171012190543_B100","doi-asserted-by":"crossref","unstructured":"Qazi S, Samuel NK, Venkatachalam TK et al. Evaluating dissolution profiles of an anti-HIV agent using ANOVA and non-linear regression models in JMP software. Int J Pharm2003; 252: 27\u201339.","DOI":"10.1016\/S0378-5173(02)00603-8"},{"key":"key\n\t\t\t\t20171012190543_B101","doi-asserted-by":"crossref","unstructured":"Venkatachalam TK, Samuel P, Li G et al. Lipase-mediated stereoselective hydrolysis of stampidine and other phosphoramidate derivatives of stavudine. Bioorg Med Chem2004; 12: 3371\u201381.","DOI":"10.1016\/j.bmc.2004.03.068"},{"key":"key\n\t\t\t\t20171012190543_B102","doi-asserted-by":"crossref","unstructured":"Venkatachalam TK, Yu G, Samuel P et al. A comparative study of the hydrolysis pathways of substituted aryl phosphoramidate vs aryl thiophosphoramidate derivatives of stavudine. Eur J Med Chem2004; 39: 665\u201383.","DOI":"10.1016\/j.ejmech.2004.04.002"},{"key":"key\n\t\t\t\t20171012190543_B103","doi-asserted-by":"crossref","unstructured":"Venkatachalam TK, Samuel P, Uckun FM. Stereochemical influence on lipase-mediated hydrolysis and biological activity of stampidine and other stavudine phosphoramidates. Bioorg Med Chem2005; 13: 1763\u201373.","DOI":"10.1016\/j.bmc.2004.12.024"},{"key":"key\n\t\t\t\t20171012190543_B104","doi-asserted-by":"crossref","unstructured":"Venkatachalam TK, Samuel P, Uckun FM. Enzymatic hydrolysis of stampidine and other stavudine phosphoramidates in the presence of mammalian proteases. Bioorg Med Chem2005; 13: 2651\u20135.","DOI":"10.1016\/j.bmc.2005.01.058"},{"key":"key\n\t\t\t\t20171012190543_B105","doi-asserted-by":"crossref","unstructured":"D'Cruz OJ, Uckun FM. Stampidine is a nonspermicidal broad-spectrum anti-human immunodeficiency virus microbicide Fertil Steril2003; 81: 831\u201341.","DOI":"10.1016\/j.fertnstert.2003.08.037"},{"key":"key\n\t\t\t\t20171012190543_B106","doi-asserted-by":"crossref","unstructured":"D'Cruz OJ, Samuel P, Waurzyniak B et al. In vivo evaluation of a gel formulation of stampidine, a novel nonspermicidal broad-spectrum anti-HIV microbicide. Am J Drug Deliv2003; 1: 275\u201385.","DOI":"10.2165\/00137696-200301040-00006"},{"key":"key\n\t\t\t\t20171012190543_B107","doi-asserted-by":"crossref","unstructured":"D'Cruz OJ, Samuel P, Waurzyniak B et al. Development and evaluation of a thermoreversible ovule formulation of stampidine, a novel nonspermicidal broad-spectrum anti-HIV microbicide. Biol Reprod2003; 69: 1843\u201351.","DOI":"10.1095\/biolreprod.103.019182"},{"key":"key\n\t\t\t\t20171012190543_B108","doi-asserted-by":"crossref","unstructured":"D'Cruz OJ, Samuel P, Uckun FM. Conceival, a novel non-contraceptive vaginal vehicle for lipophilic microbicides. AAAPS PharmSciTech2005; 6: in press. http:\/\/www.aapspharmscitech.org\/prepub\/prepub.asp (15 April 2005, date last accessed).","DOI":"10.1208\/pt060111"},{"key":"key\n\t\t\t\t20171012190543_B109","doi-asserted-by":"crossref","unstructured":"Venkatachalam TK, Tai HL, Vig R et al. Enhancing effects of a mono-bromo substitution at the para position of the phenyl moiety on the metabolism and anti-HIV activity of D4T-phenyl methoxyalaninyl phosphate derivatives. Bioorg Med Chem Lett1998; 8: 3121\u20136.","DOI":"10.1016\/S0960-894X(98)00547-2"},{"key":"key\n\t\t\t\t20171012190543_B110","doi-asserted-by":"crossref","unstructured":"Saviola JF, Hilmantel G, Rosenthal AR. The U.S. Food and Drug Administration's role in contact lens development and safety. Eye Contact Lens2003; 29: S160\u20135.","DOI":"10.1097\/00140068-200301001-00044"},{"key":"key\n\t\t\t\t20171012190543_B111","doi-asserted-by":"crossref","unstructured":"Uckun FM, Tai HL, D'Cruz OJ. Antileukemic activity and cellular metabolism of the aryl phosphate derivative of bromo-methoxy zidovudine (compound WHI-07). Arzneimittelforschung2005; 55: 50\u201365.","DOI":"10.1055\/s-0031-1296824"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/56\/1\/10\/2084889\/dki168.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,11]],"date-time":"2021-07-11T05:53:48Z","timestamp":1625982828000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/56\/1\/10\/706773\/Stampidine-a-selective-oculogenital-microbicide"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,26]]},"references-count":111,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2005,5,26]]},"published-print":{"date-parts":[[2005,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dki168","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,7]]},"published":{"date-parts":[[2005,5,26]]}}}